Sho, Masayuki
Nara Medical University
4 papers on CoChatORCID 0000-0002-6208-7661
Most cited papers
- Verified
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
Nomi, T., Sho, M., Akahori, T., Hamada, K., Kubo, A., Kanehiro, H., Nakamura, S., Enomoto, K., Yagita, H., Azuma, M., et al. (2007) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research
Cited by 889
- Verified
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
Ohigashi, Y., Sho, M., Yamada, Y., Tsurui, Y., Hamada, K., Ikeda, N., Mizuno, T., Yoriki, R., Kashizuka, H., Yane, K., et al. (2005) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersEsophageal Cancer Research and Treatment
Cited by 796
- Verified
Proinflammatory functions of vascular endothelial growth factor in alloimmunity
Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation
Transplantation: Methods and OutcomesAngiogenesis and VEGF in Cancer
Cited by 251
- Verified
Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer ( KHBO1401 ‐ MITSUBA )
Ioka, T., Kanai, M., Kobayashi, S., Sakai, D., Eguchi, H., Baba, H., Seo, S., Taketomi, A., Takayama, T., Yamaue, H., et al. (2023) · Journal of Hepato-Biliary-Pancreatic Sciences
Cholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct Disorders
Cited by 249
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free